Subgroup analysis of ECOG2 patients from ROMANA 2: A phase III study of anamorelin in NSCLC patients with cachexia.

Authors

null

Amy Pickar Abernethy

Duke University Medical Center, Durham, NC

Amy Pickar Abernethy, David Christopher Currow, Lyon L. Gleich, Ying Yan, John Friend, Jennifer S. Temel

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2014 Palliative and Supportive Care in Oncology Symposium

Session Type

Poster Session

Session Title

General Poster Session B: <span>Early Integration of Palliative Care in Cancer Care, Patient-Reported Outcomes, and Psycho-Oncology</span>

Track

Early Integration of Palliative Care in Cancer Care,Patient-Reported Outcomes: Mechanisms of Symptoms and Treatment Toxicities,Psycho-oncology,End-of-Life Care,Survivorship

Sub Track

Early Integration of Palliative Care in Cancer Care

Clinical Trial Registration Number

NCT01387282

Citation

J Clin Oncol 32, 2014 (suppl 31; abstr 6)

DOI

10.1200/jco.2014.32.31_suppl.6

Abstract #

6

Poster Bd #

A8

Abstract Disclosures

Similar Posters

First Author: Richard J.E. Skipworth

Poster

2016 Palliative and Supportive Care in Oncology Symposium

Efficacy of anamorelin in cachectic patients with non-small cell lung cancer (NSCLC) and low BMI (< 20 kg/m<sup>2</sup>): Post-hoc analysis of two phase III studies.

Efficacy of anamorelin in cachectic patients with non-small cell lung cancer (NSCLC) and low BMI (< 20 kg/m2): Post-hoc analysis of two phase III studies.

First Author: David Christopher Currow

First Author: David Christopher Currow

Poster

2015 Palliative and Supportive Care in Oncology Symposium

Anamorelin in patients with advanced non-small cell lung cancer and cachexia: Results from the phase III studies ROMANA 1 and 2.

Anamorelin in patients with advanced non-small cell lung cancer and cachexia: Results from the phase III studies ROMANA 1 and 2.

First Author: Jennifer S. Temel